Cost of Stress Urinary Incontinence: A Claims Data Analysis

Author： Birnbaum H.G.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.22, Iss.2, 2004-01, pp. : 95-105

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of Stress Urinary Incontinence with Non-Animal Stabilised Hyaluronic Acid/Dextranomer (NASHA/Dx) Gel: An Analysis of Utility and Cost

By Kobelt Gisela  

Clinical Drug Investigation, Vol. 26, Iss. 10, 2006-01 ,pp. : 583-591

Adis International

Access to resources Recommend Favorite

Cost-Effectiveness of Duloxetine: The Stress Urinary Incontinence Treatment (SUIT) Study

By Mihaylova Borislava   Pitman Richard   Tincello Douglas   van der Vaart Huub   Tunn Ralf   Timlin Louise   Quail Deborah   Johns Adam   Sculpher Mark  

Value in Health, Vol. 13, Iss. 5, 2010-08 ,pp. : 565-572

Blackwell Publishing

Access to resources Recommend Favorite

Duloxetine: In Stress Urinary Incontinence

By Paul L. McCormack   Gillian M. Keating  

Drugs, Vol. 64, Iss. 22, 2004-01 ,pp. : 2567-2573

Adis International

Access to resources Recommend Favorite

Reliability of Medicaid Claims Versus Medical Record Data: In a Cost Analysis of Palivizumab

By Julie Jacobson Vann  

PharmacoEconomics, Vol. 25, Iss. 9, 2007-01 ,pp. : 793-800

Adis International

Access to resources Recommend Favorite

Determining the cost of stress incontinence not to be sneezed at

By  

Inpharma, Vol. 1, Iss. 1423, 2004-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite